Ker wor~&" Scrotonm: 5-Hydroxytryptophan; Hippocampus: Dorsal raphe nucleus: ~,-Adrencrgic receptor 'Fhc purpose of the present study is to clarify the modulation of the biosynthesis ol'serotonin (5-HT) via the ~:-adrcnoceptors in the brain. For this purpose. 5-hydroxytryptophun 15-HTP) accumulation was determined using an HPLC-ECD system in the presence of the inhibition of aromatic I -amino acid decurboxylasc. Administration of :z2-adrenoceptor agonist, clonidine, produced a reduction of the in viw) 5-HTP accumulation in Ihe rat hippocampus and dorsal raphe nucleus. In addition, c~:-adrenoceptor antagonist, idazoxan, increased the 5-HTP accumulation m both the hippocampus and thc dorsal ruphe nucleus. In rats with catecholammergic neurons denervatcd by pretreatment with 6-bydroxydopamme, clonidine failed to produce a reduction of 5-HTP accumulation in the dorsal ruphe nucleus. On Ihe other hand, hippocumpal 5-HTP accumulation was decreased signilicantly. Brain tryptophan levels were unaffected by either clonidine or idazoxun. These results suggest that c~-adrenoceptors might m~,dulatc serotonin biosynthesis and this modulation might be related to the neuroanatomical differences in the rat brain. Anatomical studies suggest that the serotonergic neurons of the midbrain raphe nuclei are innervated by norepinephrinergic nerve terminals [2]. The firing activity of the 5-HT neurons of the rat dorsal raphe nucleus is modulated by c~-adrenoceptor agonists and antagonists [3, 23] . In addition, hippocampal formation was considerably innervated by both serotonergic and norepinephrinergic fibers [14, 16] . In hippocampal slices, electrical stimulation-induced [~H]5-HT release is inhibited via c~:-adrenoceptor stimulation [9] . Reinhard and Roth [18] reported that the systemic administration of clonidine decreased the brain cortex concentration of 5-hydoxyindoleacetic acid (5-HIAA), a major metabolite of 5-HT, Correspom/em'e. M. Yoshioka, First
Electrical stimulation of the serotonergic neurons in the CNS increases not only serotonin (5-HT) turnover [20] , but also 5-HT synthesis by the activation of tryptophan hydroxylase [4, 11] , which is the initial and ratelimiting enzyme in the biosynthesis of 5-HT. A 5-HTI. x agonist, 8-OH-DPAT, potently suppresses the firing rate of 5-HT neurons [21] and reduces 5-hydroxytryptophan (5-HTP) accumulation [8] in the rat brain. Sawada and Nagatsu [19] also reported that stimulation of the 5-HT atttoreceptors prevents the increase of 5-HT biosynthesis in rat raphe slices.
Anatomical studies suggest that the serotonergic neurons of the midbrain raphe nuclei are innervated by norepinephrinergic nerve terminals [2] . The firing activity of the 5-HT neurons of the rat dorsal raphe nucleus is modulated by c~-adrenoceptor agonists and antagonists [3, 23] . In addition, hippocampal formation was considerably innervated by both serotonergic and norepinephrinergic fibers [14, 16] . In hippocampal slices, electrical stimulation-induced [~H]5-HT release is inhibited via c~:-adrenoceptor stimulation [9] . Reinhard and Roth [18] reported that the systemic administration of clonidine decreased the brain cortex concentration of 5-hydoxyindoleacetic acid (5-HIAA), a major metabolite of 5-HT, Correspom/em'e. M. Yoshioka, First Department of Pharmacology, Ilokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Jap:.ul. Fax: (81 ) I 1-717-5286. and suggested that this inhibitory effect was mediated by decreased 5-HT release. It is conceivable, therefore, that transmitter biosynthesis may also be modulated by norepinephrine released From neighboring norepinephrinergic nerve endings in both the cell body and the nerve terminals. As with the above findings on clonidine, the neuroanatomical difference of interaction between serotonergic and norepinephrinergic neurons must also be considered in terms of 5-HT synthesis, i.e., 5-HT cell body and 5-HT nerve terminal. In the present study, we focused on neuroanatomical differences and investigated direct and/or indirect actions of c~_~-adrenoceptof mediated 5-HT synthesis in the rat brain.
Male Wistar rats (150-181) g) were obtained from the Shizuoka Laboratory Animals Center (Hamamatsu, Japan). The daily light period was set between 07.00 19.00 h. Groups of 4-6 rats received an intraperitoneal injection of clonidine, idazoxan or saline. Thirty rain thereafter, all rats received 3-hydroxybenzylhydrazine (NSD-1015, an inhibitor of aromatic L-amino acid decarboxylase, 100 mg/kg i.p.l and were decapitated 30 rain later [5] .
Brains were rapidly removed and dissected on an icecold plate to separate the hippocampus, the dorsal raphe nucleus and the rest of the brain [10, 17] . The slices were disrupted by sonication with a 5 to 10 times volume of 0.4 N perchloric acid containing 10/aM EDTA-2Na and N-methyldopamine as an internal standard. Precipitated protein was removed by centrifugation at -2°C at 10,000 rpm for 10 min. For the determination of 5-HTP in the hippocampus and the dorsal raphe nucleus, and the tryptophan in the rest of the brain, 5-50/11 of supernatant was injected into a high-performance liquid chromatograph (HPLC) apparatus consisting of a Yanagimoto VMD-101 pump, a reversed-phase column (RP-18, ODS, 5 pm particle size) and an electrochemical detector (ECD-100, Eicom, Kyoto, Japan). Applied potential for determination of 5-HTP and tryptophan was maintained at 700 mV and 900 mV vs Ag/AgC1, respectively. Catecholamines (norepinephrine and dopamine) in the rest of the brain were assayed by alumina extraction after deproteinization and measured by HPLC-ECD [15] .
In order to destroy norepinephrinergic neurons, some rats were injected i.c.v, with 6-hydroxydopamine (6-OHDA, 200 pg) 10 min after the administration of pargyline (25 mg/kg, i.p.) to prevent the destruction of serotonergic neurons. The administration of the neurotoxin was carried out with a microsyringe that was positioned with a stereotaxic apparatus at a depth of 3.3 mm below the surface of the dura mater, 1.4 mm lateral to the midline and 0.8 mm posterior to the bregma. All i.c.v, injections were made in a volume of 10/A and delivered over a period of 2 rain. Measurements were taken 14 days after the i.c.v, injection of 6-OHDA.
The following drugs were used: clonidine hydrochloride (Sigma Chemical Co., St. Louis, MO, USA), idazoxan hydrochloride (Reckitt And Colman, Hull, UK), 3-hydroxybenzylhydrazine (NSD-1015, Sigma), 6-OHDA (Sigma) and pargyline (Sigma). Data were analyzed by Dunnett's multiple range test or analysis of variance followed by the Student's t-test.
The saline control values of 5-HTP accumulation were 7.5_+0.4 (mean_+S.E.M.) and 1.9_+0,3 rig/rag protein in the dorsal raphe nucleus and the hippocampus, respectively. Clonidine (300/.tg/kg, i.p.) produced a significant reduction of this 5-HTP accumulation in both the hippocampus and the dorsal raphe nucleus (4.7_+0.9 and 0.9_+0.1 ng/mg protein, respectively: Fig. 1) . A low dose of clonidine (30pg/kg) decreased the content of 5-HTP slightly in the dorsal raphe nucleus but not significantly in either the hippocampus or the dorsal raphe nucleus. In order to determine whether clonidine was acting directly upon 5-HT neurons or indirectly through norepinephrinergic neurons, clonidine (300 ¢tg/kg, i./p,) was injected into rats which had been pretreated with 6-OHDA to destroy their norepinephrinergic neurons. The data in Table ! reveal that 6-OHDA reduced NE by greater than 80% and DA by approximately 77% without affecting the level of tryptophan (Table II) . The treatment with 6-OHDA prevented clonidine-induced 5-HTP accumulation in the dorsal raphe nucleus (8.2-+ 1.1 ng/mg protein: n.s. vs. control). In the hippocampus pretreated with 6-OHDA, clonidine still decreased 5-HTP accumulation (0.6+0.1 ng/mg protein: P<0.05 vs. control) and this reduction was greater than that in the group not treated with 6-OHDA (Fig. 1) . In addition, an ~2-adrenoceptor antagonist, idazoxan (100 llg/kg, i.p.), produced increases in 5-HTP accumulation in both the dorsal raphe nucleus (16.8 ng/mg protein; P<0.01 vs. control) and the hippocampus (3.6 ng/ mg protein: P<0.01 vs. control). As shown in Table II , these drugs showed no effects on the brain tryptophan level.
Clonidine (300/,tg/kg, i.p.) produced a reduction of 5-HTP accumulation in both the dorsal raphe nucleus and the hippocampus by approximately 40% and 50%, respectively, under aromatic k-amino acid decarboxylase inhibition. The present data are in agreement with those of Reinhard and Roth [18] who observed that clonidine administration decreased 5-HTP accumulation in the rat cerebral cortex by approximately 40%. The distribution of norepinephrinergic and serotonergic fibers appears to overlap considerably in the hippocampus [14, 16] . The possibility that 5-HT biosynthesis is directly modulated via cz2-adrenoceptors is supported by the facts that ~,-adrenoceptor antagonist, idazoxan, produced an increase in 5-HTP accumulation and that pretreatment with 6-OHDA did not affect the inhibitory effect of intraperitoneally administered clonidine. In contrast to its effect in the hippocampus, the inhibitory effect of clonidine on the 5-HT neurons in the dorsal raphe nucleus is probably indirect. This view is supported by the fact that pretreatment with 6-OHDA eliminated the inhibitory effect of intraperitoneally administered clonidine. Assuming that this dose of 6-OHDA selectively destroys catecholaminergic neurons, the inhibitory effect of clonidine in the dorsal raphe might require mediation by an intact NE system.
A lower dose of clonidine (30/ag/kg, i.p.) failed to produce a reduction of 5-HTP accumulation in either the hippocampus or the dorsal raphe nucleus. Although 30 /ag/kg of clonidine decreases blood pressure in rats [24] , this dose was insensitive to 5-HT synthesis in the present study. The possibility that high doses of clonidine suppress 5-HTP accumulation due to a systemic effect (e.g. hypotension) can be excluded because, as Togashi [24] reported, the hypotensive effect of clonidine at a dose of 30/ag/kg is saturated, and there is no significant difference in systolic blood pressure changes between 30 and 300 ~g/kg. In addition, Echizen and Freed [6] reported that during hypotension induced by nitroprusside, extracellular concentrations of NE and 5-HIAA in the rat dorsal raphe nucleus did not change significantly. Furthermore, the c~:adrenoceptor antagonist, idazoxan (100 /ag/kg, i.p.), produced an effect opposite to that of clonidine; it facilitated 5-HTP accumulation. Taken together, these data indicate that the modulation of 5-HTP accumulation is not mediated by the non-specific systemic effect of clonidine but by the specific ~-adrenoceptors. The rate of 5-HT synthesis in the brain is sensitive to changes in the concentration of its substrate, tryptophan [1, 5, 7] . The observation in the present study that clonidine or idazoxan did not alter tryptophan levels suggests that the action of these drugs on 5-HTP accumulation are not due to changes in the substrate awfilability.
It was reported that tryptophan hydroxylase activity was controlled by Ca > [13] and that this effect of calcium on the activity of tryptophan hydroxylase was mediated by the calcium-cah-nodulin-dependent phosphorylation of tryptophan hydroxylase [I 2.26] . Although the mechanism by which ~_~-adrenoceptor stilnulation inhibits neurotransmitter release has not been established, the influence on the availability of intracellular calcium to promote exocytotic release is probably involved [22, 25] . It is presumed that ~_~-adrenoceptor-mediated inhibition of tryptophan hydroxylase activity is modulated by the same mechanisrn, i.e., the reduction of calcium availability in nerve terminals and cell bodies. However. the precise mechanism of this action is uncertain.
In conclusion, it is hypothesized that ~:adrenoceptor activation inhibits 5-HT synthesis at the lryptophan hydroxylase level via prejunctional 5-HT heteroreceptors in the hippocampus and through certain catecholammergic neurons in the dorsal raphe nucleus.
